Literature Review: The impact of clinical pharmacy services on patient outcomes in chronic disease management

*Corresponding author: Muath Ibrahim AlDuhailan. Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0. Literature Review: The impact of clinical pharmacy services on patient outcomes in chronic disease management Muath Ibrahim AlDuhailan *, Fahad Abdulaziz AlSubaie, Abdulelah Abdulaziz AlMagrabi, Manahi Ayadh AlQahtani, Hassan Ahmed Salami and Ahmed Hashim AlMusallam Pharmacy Department, King Abdulaziz Hospital of National Guard Affairs, AlAhsa, Saudi Arabia. World Journal of Biology Pharmacy and Health Sciences, 2025, 23(03), 125–127 Publication history: Received on 29 July 2025; revised on 04 September 2025; accepted on 06 September 2025 Article DOI: https://doi.org/10.30574/wjbphs.2025.23.3.0814 Abstract Clinical pharmacy services have increasingly become part of healthcare systems for chronic condition management like diabetes, hypertension, and cardiovascular disease. These include medication therapy management, patient counseling, therapeutic drug monitoring, and care coordination with other health professionals. This review covers clinical outcomes, medication compliance, and healthcare use among patients with chronic illness as they are affected by clinical pharmacy interventions. The evidence indicates that clinical pharmacists significantly impact therapeutic results, hospital readmissions, and quality of life among patients. Incorporation of clinical pharmacy services within primary health care models is thus imperative to maximizing chronic diseases management. Keywords: Impact; Clinical Pharmacy; Services; Patient Outcomes; Chronic Disease; Management 1. Introduction Chronic diseases are among the main causes of morbidity and mortality globally. Treatment of such diseases may comprise complicated medication regimens and long-term follow-up. Clinical pharmacists, as part of the multidisciplinary healthcare team, are well-positioned to ensure safe, effective, and economical use of medications. Their role has evolved beyond dispensing to include direct patient care, medication reconciliation, and chronic disease education [4-6]. The need for enhanced chronic disease management strategies has placed greater emphasis on the contribution of pharmacists to clinical care. 2. Literature Review Several studies have revealed the efficacy of clinical pharmacy services to enhance outcomes in chronic disease patients. For instance, a randomized controlled trial conducted by Chisholm-Burns et al. [7] identified that pharmacist interventions favored blood pressure control in patients with hypertension. Likewise, interventions by clinical pharmacists have improved glycemic control in diabetic patients, with considerable decreases in HbA1c concentrations [8-9]. A systematic review by Wubben and Vivian [10] reported that pharmacist-managed care was associated with improved lipid profiles, reduced cardiovascular risk, and enhanced medication adherence. These findings reinforce the importance of integrating pharmacists into chronic disease care models. 3. Discussion Clinical pharmacists contribute significantly to healthcare by providing optimal pharmacotherapy, avoiding adverse drug reactions, and ensuring medication adherence. They contribute to individualized therapeutic plans based on the World Journal of Biology Pharmacy and Health Sciences, 2025, 23(03), 125–127 126 specific needs of patients through their engagement in interdisciplinary care models. Despite these benefits, implementation of clinical pharmacy services on a grand scale is thwarted by poor reimbursement mechanisms, variability in training pharmacists, and unawareness on the part of healthcare professionals and patients [11-14]. To close these gaps, policy reforms and education plans are needed to promote the expansion of clinical pharmacy practice. 4. Results Evidence from a number of studies consistently demonstrates that the delivery of clinical pharmacy services improves patient outcomes. A meta-analysis of Machado et al. [15] showed a considerable reduction in systolic and diastolic blood pressure levels in patients provided with care by pharmacists. Morgado et al. [16] demonstrated improved LDL cholesterol levels and fewer hospital admissions in patients with interventions delivered by pharmacists. In addition, such services have proved to be cost-saving, decreasing the total costs of healthcare by decreasing complications and increasing preventive care [17]. 5. Conclusion Clinical pharmacy services are critical to control chronic diseases by improving outcomes in patients and optimizing the utilization of medicines. The proof is in favor of integrating clinical pharmacists into multidisciplinary teams within healthcare, especially in primary care. They help with better control of chronic diseases, improved quality of life, and reduced healthcare costs. Future healthcare policies should be placed to increase clinical pharmacy services to meet the growing demand for controlling chronic diseases. Compliance with ethical standards Disclosure of conflict of interest No conflict of interest to be disclosed. References [1] Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy. 2007;27(4):481-93. [2] Chisholm-Burns MA, Kim Lee J, Spivey CA, et al. US pharmacists' effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010;48(10):923-33. [3] Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955-64. [4] Carter BL. Evolution of clinical pharmacy in the USA and future directions for patient care. Drugs Aging. 2016;33(3):169-77. [5] American College of Clinical Pharmacy. Standards of practice for clinical pharmacists. Pharmacotherapy. 2014;34(8):794-7. [6] Touchette DR, Doloresco F, Suda KJ, et al. Economic evaluations of clinical pharmacy services: 2001–2005. Pharmacotherapy. 2008;28(3):285-94. [7] Chisholm-Burns MA, Graff Zivin JS, Lee JK, et al. Influence of clinical pharmacists on outcomes in diabetes care: a systematic review and meta-analysis. Am J Health Syst Pharm. 2010;67(6):411-20. [8] Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28(4):421-36. [9] Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part I: Systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007;41(10):1569-82. [10] Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28(4):421-36. [11] Odum L, Whaley-Connell A. The role of the clinical pharmacist in managing the treatment of patients with type 2 diabetes. Curr Med Res Opin. 2012;28(5):803-10. World Journal of Biology Pharmacy and Health Sciences, 2025, 23(03), 125–127 127 [12] Bryant LJ, Coster G, Gamble GD, McCormick RN. General practitioners' and pharmacists' perceptions of the role of community pharmacists in delivering clinical services. Res Social Adm Pharm. 2009;5(4):347-62. [13] Al Mazroui NR, Kamal MM, Ghabash NM, et al. Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes in the United Arab Emirates. Int J Clin Pharm. 2009;31(5):621-8. [14] Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilization, costs, and patient outcomes. Cochrane Database Syst Rev. 2000;(3):CD000336. [15] Machado M, Bajcar J, Guzzo GC, et al. Sensitivity of patient outcomes to pharmacist interventions. Ann Pharmacother. 2007;41(10):1569-82. [16] Morgado M, Rolo S, Macedo AF, Pereira L, Castelo-Branco M. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. Int J Clin Pharm. 2011;33(1):132-40. [17] Iskedjian M, Einarson TR, MacKeigan LD, et al. Budget impact analysis of a pharmaceutical care program for diabetes. J Am Pharm Assoc. 2001;41(5):722-8. [18] Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169(21):1996-2002. [19] Planas LG, Crosby KM, Mitchell KD, Farmer KC. Evaluation of a hypertension medication therapy management program in patients with diabetes. J Am Pharm Assoc. 2009;49(2):164-70. [20] McDonough RP, Doucette WR. Developing collaborative working relationships between pharmacists and physicians. J Am Pharm Assoc. 2001;41(5):682-92.